Canopy Growth Stock Has Been on a Roller Coaster: Is it a Good Buy?

In their relatively small lifetime, most cannabis stocks in Canada have seen both extreme highs and massive slumps. But their volatility can be an asset.

| More on:
A cannabis plant grows.

Source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s premium investing services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Few bear markets in Canada have been as brutal as the one that the marijuana sector suffered through. From the giants of the industry to smaller players, almost all marijuana stocks experienced massive growth when the sentiment about the industry was highly positive, and legal marijuana was expected to be the next best thing.

But when it became clear that marijuana companies in Canada would have a long and arduous war with the black market products that still permeate a significant segment of the Canadian market, the sentiment began to change. It triggered a long and considerable slump, which caused many marijuana companies to lose up to 90% of their valuation over time.

However, hitting rock bottom has its perks. Many marijuana stocks experience a spike in performance even when something moderately good happens in the industry, and that’s what is happening with Canopy Growth (TSX:WEED) right now.

A fallen giant

Canopy Growth was one of the largest cannabis companies in the world at one time, and even though it’s still in the top 10 cannabis companies by market cap, it has fallen several steps. Several reasons exist, including a weak sector, government regulations, and the company’s own management and business model weaknesses.

One of the most significant internal weaknesses of the company is that, in the past, it has liberally used share dilution to raise the required cash. While this allowed the company to build its portfolio of products and facilities, that’s quite impressive, the long-term implications haven’t been in the company’s favour yet.

The stock has lost over 98.5% of its market valuation from its 2019 peak, when it traded upwards of $670 per share. Now, it’s barely hitting the double digits now. It was at low single digits a while back, but the news that the U.S. might decriminalize marijuana at a federal level triggered a strong bullish phase. The stock rose by about 200% in just two weeks but is already heading toward a correction phase.

The future

There is no doubt that the U.S. is heading toward federal decriminalization of marijuana. Two-dozen states have already legalized its recreational use, and commercial distribution is also permitted in most of these states. Still, the actual trigger, especially for producers in Canada (especially if they have a U.S. presence), would be the federal legalization of marijuana.

When that happens, buying Canopy Growth might result in significant short-term gains, but buying now may not be the best course of action. The stock may dip, and if you wait for the right time to buy, you can get an even more discounted price and capture a larger piece of growth than you would if you buy now.

Foolish takeaway

It’s important to note that most cannabis stocks in Canada might surge when the U.S. government legalizes cannabis, but for almost all of them, the growth will have two phases.

The initial sentiment-driven phase would push nearly all stocks up — some more; some less. Then, after a correction, there might be a second phase of growth for companies that have actually benefited from this legalization, as evidenced by their financials.  

Should you invest $1,000 in Constellation Software right now?

Before you buy stock in Constellation Software, consider this:

The Motley Fool Stock Advisor Canada analyst team just identified what they believe are the Top Stocks for 2025 and Beyond for investors to buy now… and Constellation Software wasn’t one of them. The Top Stocks that made the cut could potentially produce monster returns in the coming years.

Consider MercadoLibre, which we first recommended on January 8, 2014 ... if you invested $1,000 in the “eBay of Latin America” at the time of our recommendation, you’d have $20,697.16!*

Stock Advisor Canada provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month – one from Canada and one from the U.S. The Stock Advisor Canada service has outperformed the return of S&P/TSX Composite Index by 29 percentage points since 2013*.

See the Top Stocks * Returns as of 3/20/25

This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium service or advisor. We’re Motley! Questioning an investing thesis — even one of our own — helps us all think critically about investing and make decisions that help us become smarter, happier, and richer, so we sometimes publish articles that may not be in line with recommendations, rankings or other content.

Fool contributor Adam Othman has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.

Confidently Navigate Market Volatility: Claim Your Free Report!

Feeling uneasy about the ups and downs of the stock market lately? You’re not alone. At The Motley Fool Canada, we get it — and we’re here to help. We’ve crafted an essential guide designed to help you through these uncertain times: "5-Step Checklist: How to Prepare Your Portfolio for Volatility."

Don't miss out on this opportunity for peace of mind. Just click below to learn how to receive your complimentary report today!

Get Our Free Report Today

More on Cannabis Stocks

a person watches a downward arrow crash through the floor
Stocks for Beginners

Plummet Alert: Is This TSX Growth Stock a Bargain or a Falling Knife?

This growth stock was once a major winner, but can investors wait for more?

Read more »

Medicinal research is conducted on cannabis.
Cannabis Stocks

What to Know About Canadian Cannabis Stocks for 2025

Let's dive into two top Canadian cannabis stocks and where they may be headed from here (given the recent moves…

Read more »

Researcher works in hemp field
Cannabis Stocks

Aurora Cannabis Stock Is up 46% in 2025: Are Investors Going From 5 Years of Pain to a 2025 Gain?

Shares of Aurora Cannabis have staged a comeback in 2025, outpacing the broader markets comfortably. Is ACB stock a good…

Read more »

A plant grows from coins.
Stocks for Beginners

3 Growth Stocks That Could Skyrocket in 2025 and Beyond

It could be a big year for these sectors, and these growth stocks in particular throughout 2025.

Read more »

money goes up and down in balance
Tech Stocks

2 TSX Stocks to Buy and 2 to Avoid in the Looming Trade War

The looming U.S.-Canada trade war has changed the business environment. Here are some TSX stocks to buy and avoid in…

Read more »

space ship model takes off
Cannabis Stocks

2 Canadian Stocks With Strong Momentum for 2025

Celestica Inc. (TSX:CLS) stock and Dollarama (TSX:DOL) stock have sustained strong price growth momentum for a long time.  Here’s why…

Read more »

Worker tags plants at an industrial cannabis operation
Cannabis Stocks

Pot Stocks: Buy, Sell, or Hold in 2025?

Cannabis stocks remain a bit risky, but could long-term investors be in for more pain or far more profits?

Read more »

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Cannabis Stocks

Could the Cannabis Bubble Re-Inflate?

Let's dive into the question of whether the Canadian cannabis bubble can re-inflate from here.

Read more »